Viewing Study NCT07206758

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2026-01-10 @ 3:20 PM
Study NCT ID: NCT07206758
Status: RECRUITING
Last Update Posted: 2025-11-18
First Post: 2025-09-26
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Immune Thrombocytopenia View
Keywords: